Q2 2022 Amgen Inc Earnings Call Transcript

Aug 04, 2022 / 09:00PM GMT
Operator

My name is Jason, and I will be your conference facilitator today for Amgen's Second Quarter 2022 Financial Results Conference Call. (Operator Instructions)

I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.

Arvind Sood - Amgen Inc. - VP of IR

Okay, Jason, thank you. Good afternoon, everybody, and welcome to our Q2 call. Lots to cover today, so we'll go ahead and jump right in.

Some of the key themes you'll hear about today include continued volume-driven growth, our strategy of seeking both internal and external innovation, the latter exemplified by our announcement this morning of acquiring ChemoCentryx. And lastly, navigating through a difficult macro environment. We have posted the slides for your background, we'll use non-GAAP financial measures in our presentation today and some of the statements will be forward-looking. Our SEC filings identify factors that could cause our actual results to differ materially.

So with that, I would like to turn the call over to our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot